Publication | Closed Access

Serotoninergic receptor activation by dextrofenfluramine enhances the blunted pituitary-adrenal responsiveness to corticotropin-releasing hormone in obese subjects

ObesityMetabolic SyndromeDextrofenfluramine EnhancesSerotoninergic Receptor ActivationMedicineEndocrine MechanismPhysiologyNeuroendocrine MechanismNeuroendocrine DisorderHypothalamic PeptideEndocrinologyPharmacologyPituitary-adrenal ResponsivenessGastrointestinal Peptide HormoneHealth Sciences